Skip to main content
Premium Trial:

Request an Annual Quote

Bioneer Develops Ebola MDx Kit in Partnership with Nigerian Biotech Agency

NEW YORK (GenomeWeb) — South Korean molecular diagnostics firm Bioneer announced on Wednesday the availability of a molecular test kit for the Ebola virus that it has developed in collaboration with the Nigerian National Biotechnology Development Agency (NABDA).

Specifically, the company's AccuPower EBOV real-time RT-PCR kit is optimized for detection of the Zaire subtype of the Ebola virus associated with recent outbreaks in Africa. Bioneer has worked with NABDA since April to develop means to rapidly detect this subtype.

The new kit is currently in limited use by NABDA, and Bioneer plans to make it available for use throughout Africa, a company spokesperson said.

Bioneer recently presented details about the kit at an Ebola virus-related workshop held by NABDA in Abuja, Nigeria, where the company trained symposium attendees on the firm's ExiStation real-time PCR system, as well as on the assay's use, outlining how it could provide early diagnosis of viral infection and quantitative analysis of viral load during treatment.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more